Chinook Therapeutics Inc (NASDAQ:KDNY)

23.51
Delayed Data
As of 4:00pm ET
 +0.95 / +4.21%
Today’s Change
11.16
Today|||52-Week Range
24.13
+44.14%
Year-to-Date

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Chinook Therapeutics Inc have a median target of 33.00, with a high estimate of 51.00 and a low estimate of 28.00. The median estimate represents a +40.37% increase from the last price of 23.51.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Chinook Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.79
Sales
$114.3K
Reporting Date
Apr 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.82%
 
 
 
 
 
 
Growthannually -21.68%
 
 
 
 
 
 

Sales

Growthquarterly -95.43%
 
 
 
 
 
 
Growthannually -89.42%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.